Open Public Meetings Act and Administrative Procedure Act; exception as technical review committee.
(1) Meetings of the pharmacy and therapeutics committee comply with the provisions of the Open Public Meetings Act, chapter
42.30 RCW, and are subject to the provisions of the Administrative Procedure Act, chapter
34.05 RCW, as applicable.
(2) The pharmacy and therapeutics committee constitutes a technical review committee created to facilitate the development, acquisition, or implementation of the Washington preferred drug list, for the purposes of state purchased health care under RCW
41.05.026, and may hold an executive session in accordance with chapter
42.30 RCW during any regular or special meeting to discuss information submitted in accordance with RCW
41.05.026.
[Statutory Authority: RCW
41.05.021,
41.05.160, and
69.41.190. WSR 16-16-083, § 182-50-015, filed 7/29/16, effective 8/29/16. Statutory Authority: RCW
41.05.160; 2004 1st sp.s. c 29 § 10. WSR 04-06-021 (Order 03-02), § 182-50-015, filed 2/23/04, effective 3/25/04.]